Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2017
/
Article
/
Tab 2
/
Research Article
First-Line
Helicobacter pylori
Eradication in Patients with Chronic Kidney Diseases in Taiwan
Table 2
Major outcomes of eradication therapy.
ā
Eradication rate
ā
CKD
Non-CKD
value
Per-protocol
85.4% (111/130)
85.7% (538/628)
0.933
Adverse event
3.1% (4/130)
4.6% (29/628)
0.433
Compliance
100.0% (130/130)
99.8% (627/628)
0.649
CKD: chronic kidney disease.